The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 18 August 2003. doi:10.1084/jem.20030767
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDonald, J. P.
Right arrow Articles by Gearhart, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDonald, J. P.
Right arrow Articles by Gearhart, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/8/635 $5.00
The Journal of Experimental Medicine, Volume 198, Number 4, 635-643

129-derived Strains of Mice Are Deficient in DNA Polymerase {iota} and Have Normal Immunoglobulin Hypermutation

John P. McDonald1, Ekaterina G. Frank1, Brian S. Plosky1, Igor B. Rogozin2, Chikahide Masutani3, Fumio Hanaoka3,4, Roger Woodgate1 and Patricia J. Gearhart5

1 Section on DNA Replication, Repair, and Mutagenesis, Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
2 National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894
3 Graduate School of Frontier Biosciences, Osaka University, and CREST, Japan Science and Technology Corporation, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan
4 RIKEN (The Institute of Physical and Chemical Research), Wako-shi, Saitama 351-0198, Japan
5 Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224

Address correspondence to Roger Woodgate, Laboratory of Genomic Integrity, Building 6, Room 1A13, NICHD, NIH, 9000 Rockville Pike, Bethesda, MD 20892-2725. Phone: 301-496-6175; Fax: 301-594-1135; email: woodgate{at}helix.nih.gov

Recent studies suggest that DNA polymerase {eta} (pol{eta}) and DNA polymerase {iota} (pol{iota}) are involved in somatic hypermutation of immunoglobulin variable genes. To test the role of pol{iota} in generating mutations in an animal model, we first characterized the biochemical properties of murine pol{iota}. Like its human counterpart, murine pol{iota} is extremely error-prone when catalyzing synthesis on a variety of DNA templates in vitro. Interestingly, when filling in a 1 base-pair gap, DNA synthesis and subsequent strand displacement was greatest in the presence of both pols {iota} and {eta}. Genomic sequence analysis of Poli led to the serendipitous discovery that 129-derived strains of mice have a nonsense codon mutation in exon 2 that abrogates production of pol{iota}. Analysis of hypermutation in variable genes from 129/SvJ (Poli-/-) and C57BL/6J (Poli+/+) mice revealed that the overall frequency and spectrum of mutation were normal in pol{iota}-deficient mice. Thus, either pol{iota} does not participate in hypermutation, or its role is nonessential and can be readily assumed by another low-fidelity polymerase.

Key Words: genomic organization • immunoglobulin variable genes • DNA polymerase {eta} • cytosine deamination • base excision repair


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS